This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Piskur P, Sonc M, Cufer T, Borstnar S, Mrhar A.Pharmacoeconomic aspects of adjuvant anastrozole or tamoxifen in breast cancer: a Slovenian perspective. Anti-Cancer Drugs 17: 719-724, No. 6, Jul 2006
Rights and permissions
About this article
Cite this article
Anastrozole cost effective in HR+ early breast cancer?. Pharmacoecon. Outcomes News 509, 8 (2006). https://doi.org/10.2165/00151234-200605090-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605090-00022